Clinical Trial to Assess the Efficacy and Safety of YYD601 in the Treatment of Esophageal Reflux Disease (ERD)
Status:
Completed
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, double-dummy, active comparator, multi-centers, non-inferiority
design clinical trial to assess the efficacy and safety of YYD601 in ERD patients (phase 3).